These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
941 related articles for article (PubMed ID: 32450344)
1. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Viecca M; Radovanovic D; Forleo GB; Santus P Pharmacol Res; 2020 Aug; 158():104950. PubMed ID: 32450344 [TBL] [Abstract][Full Text] [Related]
2. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Ahmed S; Zimba O; Gasparyan AY Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease. Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D Emerg Infect Dis; 2020 Aug; 26(8):1941-1943. PubMed ID: 32348233 [TBL] [Abstract][Full Text] [Related]
4. Viral Coagulopathy in Patients With COVID-19: Treatment and Care. Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019]. Xu Y; Qian Y; Gu Q; Tang J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347 [TBL] [Abstract][Full Text] [Related]
6. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
7. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study. Ramiro S; Mostard RLM; Magro-Checa C; van Dongen CMP; Dormans T; Buijs J; Gronenschild M; de Kruif MD; van Haren EHJ; van Kraaij T; Leers MPG; Peeters R; Wong DR; Landewé RBM Ann Rheum Dis; 2020 Sep; 79(9):1143-1151. PubMed ID: 32719045 [TBL] [Abstract][Full Text] [Related]
8. [A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation]. Xie W; Zhong Z; Li G; Hou G; Huang K; Yu Z Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):677-680. PubMed ID: 32684211 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Tang N; Bai H; Chen X; Gong J; Li D; Sun Z J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112 [TBL] [Abstract][Full Text] [Related]
10. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063 [TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports. Guo D; Pan S; Wang M; Guo Y Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433 [TBL] [Abstract][Full Text] [Related]
12. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Salamanna F; Maglio M; Landini MP; Fini M Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915 [TBL] [Abstract][Full Text] [Related]
13. Coagulopathy of Coronavirus Disease 2019. Iba T; Levy JH; Levi M; Connors JM; Thachil J Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443 [TBL] [Abstract][Full Text] [Related]
14. Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism. Haque S; Jawed A; Akhter N; Dar SA; Khan F; Mandal RK; Areeshi MY; Lohani M; Wahid M Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9244-9245. PubMed ID: 33015764 [No Abstract] [Full Text] [Related]
15. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue? Breakey N; Escher R Swiss Med Wkly; 2020 May; 150():w20293. PubMed ID: 32459857 [TBL] [Abstract][Full Text] [Related]
16. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better? Bendjelid K; Giraud R; Von Düring S Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550 [No Abstract] [Full Text] [Related]
17. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019. Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672 [TBL] [Abstract][Full Text] [Related]
18. Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report. Shawkat A; Merrell ET; Fadel GA; Amzuta I; Amin H; Shah AJ; Habeb H; Aiash H Am J Case Rep; 2020 Jul; 21():e925786. PubMed ID: 32694498 [TBL] [Abstract][Full Text] [Related]
19. D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury: A case series. Wang X; Du B; Li J; Wang S; Wang X; Guo M; Yang B; Si D; Bai O Medicine (Baltimore); 2020 Jul; 99(31):e21513. PubMed ID: 32756189 [TBL] [Abstract][Full Text] [Related]
20. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction. Akşit E; Kırılmaz B; Gazi E; Aydın F Balkan Med J; 2020 Jun; 37(4):233-233. PubMed ID: 32326691 [No Abstract] [Full Text] [Related] [Next] [New Search]